Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ROOLIFE GROUP LTD Director's Dealing 2021

Feb 28, 2021

65712_rns_2021-02-28_542b622f-e346-4fd2-98e0-5f3ef5ddc1d7.pdf

Director's Dealing

Open in viewer

Opens in your device viewer

Rule 3.19A.2

Appendix 3Y

Change of Director's Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX's property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity RooLife Group Ltd
ABN 14 613 410 398

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director Warren Barry
Date of last notice 8 October 2020

Part 1 - Change of director's relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of "notifiable interest of a director" should be disclosed in this part.

Direct or indirect interest Indirect interest
Nature of indirect interest(including registered holder)Note: Provide details of the circumstances giving rise to therelevant interest. Barry Consulting Pty Ltd ATF Barry Family Trust(Mr Barry is a beneficiary of this trust)
Barry Family Super Fund (Mr Barry is a memberof the Fund)
Date of change 25 February 2021

+ See chapter 19 for defined terms.

No. of securities held prior to change 23,857,142 Fully Paid Ordinary Shares.
1,000,000 listed Options exercisable at $0.05 on or before
31 October 2021
8,000,000 Executive Officer Options expiring 5 February2024 with an exercise price of $0.055 subject to thefollowing vesting conditions:
-2,400,000: Vesting Condition will be taken to havebeen met if, for any consecutive trading day periodbetween the date of the grant of the ExecutiveOfficer Options and 5 February 2021, the VWAP ofthe Company's Shares is equal to or greater than$0.055 per share.
-2,400,000: Vesting Condition will be taken to havebeen met if, for any consecutive trading day periodbetween the date of the grant of the ExecutiveOfficer Options and 5 February 2022, the VWAP ofthe Company's Shares is equal to or greater than$0.08 per share.
-3,200,000: Vesting Condition will be taken to havebeen met if, for any consecutive trading day periodbetween the date of the grant of the ExecutiveOfficer Options and 5 February 2023, the VWAP ofthe Company's Shares is equal to or greater than$0.12 per share.
-All Executive Officer Options also have a time-basedvesting condition of 5 February 2023
Class Fully Paid Ordinary Shares
Number acquired 250,000 Fully Paid Ordinary Shares
Number disposed Nil
Value/ConsiderationNote: If consideration is non-cash, provide details and estimatedvaluation $0.025Per Share

+ See chapter 19 for defined terms.

No. of securities held after change 24,107,142 Fully Paid Ordinary Shares.
1,000,000 listed Options exercisable at $0.05 on or before31 October 2021
8,000,000 Executive Officer Options expiring 5 February2024 with an exercise price of $0.055 subject to thefollowing vesting conditions:
-2,400,000: Vesting Condition will be taken to havebeen met if, for any consecutive trading day periodbetween the date of the grant of the ExecutiveOfficer Options and 5 February 2021, the VWAP ofthe Company's Shares is equal to or greater than$0.055 per share.
-2,400,000: Vesting Condition will be taken to havebeen met if, for any consecutive trading day periodbetween the date of the grant of the ExecutiveOfficer Options and 5 February 2022, the VWAP ofthe Company's Shares is equal to or greater than$0.08 per share.
-3,200,000: Vesting Condition will be taken to havebeen met if, for any consecutive trading day periodbetween the date of the grant of the ExecutiveOfficer Options and 5 February 2023, the VWAP ofthe Company's Shares is equal to or greater than$0.12 per share.
-All Executive Officer Options also have a time-basedvesting condition of 5 February 2023
Nature of changeExample: on-market trade, off-market trade, exercise of options,issue of securities under dividend reinvestment plan, participationin buy-back Off Market Transfer

Part 2 – Change of director's interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of "notifiable interest of a director" should be disclosed in this part.

Detail of contract N/A
Nature of interest N/A
Name of registered holder(if issued securities) N/A

+ See chapter 19 for defined terms.

Date of change N/A
No. and class of securities to which interestrelated prior to changeNote: Details are only required for a contract in relation to whichthe interest has changed N/A
Interest acquired N/A
Interest disposed N/A
Value/ConsiderationNote: If consideration is non-cash, provide details and an estimatedvaluation N/A
Interest after change N/A

Part 3 – +Closed period

Were the interests inthe securities or contracts detailed above traded duringa+closed periodwhere prior written clearance was required? No
If so, was prior written clearance provided to allow the trade to proceed duringthis period? N/A
If prior written clearance was provided, on what date was this provided? N/A

+ See chapter 19 for defined terms.

Rule 3.19A.2

Appendix 3Y

Change of Director's Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX's property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity RooLife Group Ltd
ABN 14 613 410 398

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director Grant Pestell
Date of last notice 8 October 2020

Part 1 - Change of director's relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of "notifiable interest of a director" should be disclosed in this part.

Direct or indirect interest Direct/Indirect interest
Nature of indirect interest(including registered holder)Note: Provide details of the circumstances giving rise to the relevantinterest. MrGAandMrsBPestellATFPestellSuperannuation Fund.DigrevniInvestmentsPtyLtd(Digrevni),Artemis Corporate Limited (Artemis) and StormEnterprises Pty Ltd(Storm), all of which MrPestell has a relevant interest by virtue of a noncontrollinginterest in each.
Date of change 25 February 2021

+ See chapter 19 for defined terms.

No. of securities held prior to change 6,576,626fully paid ordinary shares
1,500,000 unlisted options exercisable at $0.35 eachon or before 30 June 2021
1,500,000 unlisted options exercisable at $0.40eachon or before 30 June2023
4,350,000 listed Options exercisable at $0.05 on orbefore 31 October 2021
Class Fully Paid Ordinary Shares
Number acquired 500,000 Fully Paid Ordinary Shares
Number disposed Nil
Value/ConsiderationNote: If consideration is non-cash, provide details and estimatedvaluation $0.025per share
No. of securities held after change 7,076,626fully paid ordinary shares
1,500,000 unlisted options exercisable at $0.35 eachon or before 30 June 2021
1,500,000 unlisted options exercisable at $0.40eachon or before 30 June2023
4,350,000 listed Options exercisable at $0.05 on orbefore 31 October 2021
Nature of changeExample: on-market trade, off-market trade, exercise of options,issue of securities under dividend reinvestment plan, participation inbuy-back Off Market Trade

+ See chapter 19 for defined terms.

Part 2 – Change of director's interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of "notifiable interest of a director" should be disclosed in this part.

Detail of contract N/A
Nature of interest N/A
Name of registered holder(if issued securities) N/A
Date of change N/A
No. and class of securities to which interestrelated prior to changeNote: Details are only required for a contract in relation to whichthe interest has changed N/A
Interest acquired N/A
Interest disposed N/A
Value/ConsiderationNote: If consideration is non-cash, provide details and an estimatedvaluation N/A
Interest after change N/A

Part 3 – +Closed period

Were the interests in the securities or contracts detailed aboveduring a +closed periodtradedwhere prior written clearance wasrequired? No
If so, was prior written clearance provided to allow the trade toproceed during this period? N/A
If prior written clearance was provided, on what date was thisprovided? N/A

+ See chapter 19 for defined terms.

Rule 3.19A.2

Appendix 3Y

Change of Director's Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX's property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity RooLife Group Ltd
ABN 14 613 410 398

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director Bryan Carr
Date of last notice 8 October 2020

Part 1 - Change of director's relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of "notifiable interest of a director" should be disclosed in this part.

Direct or indirect interest Indirect interest
Nature of indirect interest(including registered holder)Note: Provide details of the circumstances giving rise to therelevant interest. Bryan EdwardCarrATF Shabaz Family Trust(MrCarris a beneficiary of this trust)
Date of change 25 February 2021
No. of securities held prior to change 12,000,000 Fully Paid Ordinary Shares.
1,642,857 listed Options exercisable at $0.05 on or before31 October 2021
12,000,000 Executive Officer Options expiring 5 February2024 with an exercise price of $0.055 subject tothe following vesting conditions:
-3,600,000: Vesting Condition will be taken to havebeen met if, for any consecutive trading day periodbetween the date of the grant of the ExecutiveOfficer Options and 5 February 2021, the VWAP ofthe Company's Shares is equal to or greater than$0.055 per share.
--3,600,000: Vesting Condition will be taken to havebeen met if, for any consecutive trading day periodbetween the date of the grant of the ExecutiveOfficer Options and 5 February 2022, the VWAP ofthe Company's Shares is equal to or greater than$0.08 per share.
--4,800,000: Vesting Condition will be taken to havebeen met if, for any consecutive trading day periodbetween the date of the grant of the ExecutiveOfficer Options and 5 February 2023, the VWAP ofthe Company's Shares is equal to or greater than$0.12 per share.
All Executive Officer Options also have a time-basedvesting condition of 5 February 2023.
Class Fully Paid Ordinary Shares
Number acquired 250,000 Fully Paid Ordinary Shares
Number disposed Nil
Value/ConsiderationNote: If consideration is non-cash, provide details and estimatedvaluation $0.025Per Share

+ See chapter 19 for defined terms.

No. of securities held after change
12,250,000 Fully Paid Ordinary Shares.
1,642,857 listed Options exercisable at $0.05 on or before31 October 2021
12,000,000 Executive Officer Options expiring 5 February2024 with an exercise price of $0.055 subject tothe following vesting conditions:
-3,600,000: Vesting Condition will be taken to havebeen met if, for any consecutive trading day periodbetween the date of the grant of the ExecutiveOfficer Options and 5 February 2021, the VWAP ofthe Company's Shares is equal to or greater than$0.055 per share.-
-3,600,000: Vesting Condition will be taken to havebeen met if, for any consecutive trading day periodbetween the date of the grant of the ExecutiveOfficer Options and 5 February 2022, the VWAP ofthe Company's Shares is equal to or greater than$0.08 per share.-
-4,800,000: Vesting Condition will be taken to havebeen met if, for any consecutive trading day periodbetween the date of the grant of the ExecutiveOfficer Options and 5 February 2023, the VWAP ofthe Company's Shares is equal to or greater than$0.12 per share.
-All Executive Officer Options also have a time-basedvesting condition of 5 February 2023.
Nature of changeExample: on-market trade, off-market trade, exercise of options,issue of securities under dividend reinvestment plan, participationin buy-back Off Market Transfer

Part 2 – Change of director's interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of "notifiable interest of a director" should be disclosed in this part.

Detail of contract N/A
Nature of interest N/A
Name of registered holder(if issued securities) N/A

+ See chapter 19 for defined terms.

Date of change N/A
No. and class of securities to which interestrelated prior to changeNote: Details are only required for a contract in relation to whichthe interest has changed N/A
Interest acquired N/A
Interest disposed N/A
Value/ConsiderationNote: If consideration is non-cash, provide details and an estimatedvaluation N/A
Interest after change N/A

Part 3 – +Closed period

Were theinterests in the securities or contracts detailed above traded duringa+closed periodwhere prior written clearance was required? No
If so, was prior written clearance provided to allow the trade to proceed duringthis period? N/A
If prior written clearance was provided, on what date was this provided? N/A

+ See chapter 19 for defined terms.